Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium

Madhusudana R. Chaluvadi, Ryan D. Kinloch, Beatrice A. Nyagode, Terrilyn A. Richardson, Malik J. Raynor, Melanie Sherman, Leposava Antonovic, Henry W. Strobel, Dirck L. Dillehay and Edward T. Morgan
Drug Metabolism and Disposition February 2009, 37 (2) 366-374; DOI: https://doi.org/10.1124/dmd.108.024240
Madhusudana R. Chaluvadi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan D. Kinloch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrice A. Nyagode
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terrilyn A. Richardson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malik J. Raynor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melanie Sherman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leposava Antonovic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry W. Strobel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirck L. Dillehay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward T. Morgan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We reported previously that infection of C3H/HeOuJ (HeOu) mice with the murine intestinal pathogen Citrobacter rodentium caused a selective modulation of hepatic cytochrome P450 (P450) gene expression in the liver that was independent of the Toll-like receptor 4. However, HeOu mice are much more sensitive to the pathogenic effects of C. rodentium infection, and the P450 down-regulation was associated with significant morbidity in the animals. Here, we report that oral infection of C57BL/6 mice with C. rodentium, which produced only mild clinical signs and symptoms, produced very similar effects on hepatic P450 expression in this strain. As in HeOu mice, CYP4A mRNAs and proteins were among the most sensitive to down-regulation, whereas CYP4F18 was induced. CYP2D9 mRNA was also induced 8- to 9-fold in the C57BL/6 mice. The time course of P450 regulation followed that of colonic inflammation and bacterial colonization, peaking at 7 to 10 days after infection and returning to normal at 15 to 24 days as the infection resolved. These changes also correlated with the time course of significant elevations in the serum of the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor-α, as well as of interferon-γ and IL-2, with serum levels of IL-6 being markedly higher than those of the other cytokines. Intraperitoneal administration of C. rodentium produced a rapid down-regulation of P450 enzymes that was quantitatively and qualitatively different from that of oral infection, although CYP2D9 was induced in both models, suggesting that the effects of oral infection on the liver are not due to bacterial translocation.

Footnotes

  • This was supported by the National Institutes of Health [Grants GM46897, DK072372, NS44174, AR002157, AI056067-01].

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.108.024240.

  • ABBREVIATIONS: P450, cytochrome P450; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; EPEC, enteropathogenic Escherichia coli; HeOu, C3H/HeOuJ; HeJ, C3H/HeJ; CFU, colony-forming unit; RT, reverse transcriptase; PCR, polymerase chain reaction; IL, interleukin; TNF-α, tumor necrosis factor-α; IFN-γ, interferon-γ; MIP-1α, macrophage inflammatory protein 1α; MCP-1, monocyte chemotactic protein-1; KC, chemokine CXCL1; RANTES, chemokine CCL5; ANOVA, analysis of variance; p.i., postinfection.

  • ↵ Embedded Image The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material.

    • Received August 28, 2008.
    • Accepted October 23, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (2)
Drug Metabolism and Disposition
Vol. 37, Issue 2
1 Feb 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium

Madhusudana R. Chaluvadi, Ryan D. Kinloch, Beatrice A. Nyagode, Terrilyn A. Richardson, Malik J. Raynor, Melanie Sherman, Leposava Antonovic, Henry W. Strobel, Dirck L. Dillehay and Edward T. Morgan
Drug Metabolism and Disposition February 1, 2009, 37 (2) 366-374; DOI: https://doi.org/10.1124/dmd.108.024240

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Regulation of Hepatic Cytochrome P450 Expression in Mice with Intestinal or Systemic Infections of Citrobacter rodentium

Madhusudana R. Chaluvadi, Ryan D. Kinloch, Beatrice A. Nyagode, Terrilyn A. Richardson, Malik J. Raynor, Melanie Sherman, Leposava Antonovic, Henry W. Strobel, Dirck L. Dillehay and Edward T. Morgan
Drug Metabolism and Disposition February 1, 2009, 37 (2) 366-374; DOI: https://doi.org/10.1124/dmd.108.024240
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolic enzymes in nintedanib metabolism
  • Mechanism of AO Inactivation by Hydralazine
  • Warfarin PBPK modeling with target binding
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics